Trial Procedures
RECRUITMENT
Participants underwent assessments at baseline (prior to the first clinic visit), 2 days after their clinic visit, and at 90 days after recruitment. At baseline, we collected demographic information, medication adherence, motivation to maintain medication adherence, and AF knowledge. Race and ethnicity were self-reported by study participants and categorized as Aboriginal or Torres Strait Islander, Asian (including North, East, and South-East Asian), Middle-East and North African, White, and other (including Central and South American, Pacific Islander, Polynesian, and Sub-Saharan African). Race and ethnicity were included in analysis to account for differences in intervention impact among participants of different sociocultural backgrounds. Time of AF diagnosis was not collected; hence, duration of AF could not be calculated. At the postclinic assessment (defined as 2 days postvisit), we collected information on satisfaction with clinical care, motivation to maintain medication adherence, and AF knowledge. At the 90-day follow-up, we collected information on medication adherence, motivation to maintain medication adherence, and AF knowledge. Patient characteristics and outcomes were collected with a combination of medical record review by trained research assistants and participant self-report.